Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptide

Transplantation

Volumn 63, Issue 7, 1997, Pages 1004-1011

  Giral, Magali ^a   Cuturi, Maria Cristina ^b   Nguyen, Jean Michel ^d   Josien, Régis ^a,b   Dantal, Jacques ^a   Floc'h, Robert ^c   Buelow, Roland ^e   Pouletty, Philippe ^e   Soulillou, Jean Paul ^a,b  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

^c INSTITUT DE BIOLOGIE   (France)

^d UNIVERSITÉ DE NANTES   (France)

^e GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRAP 2702; HLA ANTIGEN CLASS 1; HLA B 2702; HLA B ANTIGEN; PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031002119     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704150-00017     Document Type: Article

References (29)

1. Cuturi MC, Blancho G, Josien R, Soulillou JP. The biology of allograft rejection. Curr Opin Nephrol Hypertension 1994; 3: 578.
2. Foster S, Wood KJ, Morris JW. The effectiveness of pretreatment with soluble or membrane-bound donor class I major histocompatibility complex antigens in the induction of unresponsiveness to a subsequent rat renal allograft. Transplantation 1992; 53: 1322.
3. Priestley CA, Dalchau R, Sawyer GJ, Fabre JW. A detailed analysis of the potential of water-soluble classical class I MHC molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses. Transplantation 1989; 48: 1031.
4. Spencer SC, Fabre JW. Bulk purification of a naturally occurring soluble form of RT1-A class I major histocompatibility complex antigens from DA rat liver, and studies of specific immunosuppression. Transplantation 1987; 44: 141.
5. Hamashima T, Stepkowski SM, Smith S, Kahan B. Induction of transplantation tolerance by a single intrathymic injection of 3 M KCl-extracted donor histocompatibility antigens combined with two doses of anti-rat a/b T cell receptor monoclonal antibodies. Transplantation 1994; 58: 105.
6. Clayberger C, Rosen M, Parham P, Krensky AM. Recognition of an HLA public determinant (Bw4) by human allogenic cytotoxic T lymphocytes. J Immunol 1990; 144: 4172.
7. Clayberger C, Lyn SC, Krensky AM. Peptides corresponding to TC receptor HLA contact region inhibit class I-restricted immune responses. Transplant Proc 1993; 45: 477.
8. Barnstable CJ, Snary D, Crumpton MJ, Bodmer WF. The structure and evolution of the HLA-Bw4 and Bw6 antigens. Tissue Antigens 1979; 13: 334.
9. Colonna M, Borsellino G, Falco M, Ferrarra GB, Strominger JL. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1 and NK2 specific natural killer cells. Proc Natl Acad Sci USA 1993; 90: 12000.
10. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive-HLA alleles with isoleucine 80. J Exp Med 1994; 180: 1233.
11. Stagsted J, Reaven GM, Hansen T, Goldstein A, Olsson L. Regulation of insulin receptor functions by a peptide derived from major histocompatibility complex class I antigen. Cell 1990; 62: 297.
12. Stagsted J, Ziehe S, Satoh S, Holman GD, Cushman SW, Olsson L. Insulinomimetic effect on glucose transport by epidermal growth factor when combined with a major histocompatibility complex class I derived peptide. J Biol Chem 1993; 268:1770-1774.
13. Nisco S, Vriens P, Hoyt G, et al. Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A. J Immunol 1994; 152: 3786.
14. Cuturi MC, Josien R, Douillard P. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a. 75-84) from the a1 helix of the first domain of HLA-B7 01. Transplantation 1995; 59: 661.
15. Gao L, Woo J, Buelow R. Both L- and D-isomers of allotrap 2702 prolong heart allograft survival in mice. Heart Lung Transplant 1996; 15: 78.
16. Solez K, Benediktsonn H, Burdick JF, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
17. Cantarovich D, Bignon JD, Cesbron A, Robillard N, Soulillou JP. Monitoring of antithymocyte globulin therapy by the rosette test. Transplant Clin Immunol 1992; 24: 221.
18. Rowland M, Tozer TN. Clinical pharmacokinetics-concepts and applications. Philadelphia: Lea & Febiger, 1980: 459.
19. Gibaldi M, Perrier D. Pharmacokinetics drugs and the pharmaceutical science. Dekker, 1985: 459.
20. Soulillou JP, Cantarovich D, Le Mauff B. Randomized trial of an anti-interleukin 2 receptor monoclonal antibody (33B3.1) versus rabbit antithymocyte globulin (ATG) in prophylaxis of early rejection in human renal transplantation. N Engl J Med 1990; 322: 1175.
21. Fisher RA. Statistical methods and scientific interference, 3rd ed. London: Collier Macmillan, 1973.
22. Guillou PJ, Hegarty J, Ramsden C, Davison AN, Wrill EJ, Giles GR. Changes in human natural killer activity early and late after renal transplantation using conventional immunosuppression. Transplantation 1982; 33: 414.
23. Jameson BA, McDonnell JM, Marini JC, Korngold R. A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature 1994; 368: 744.
24. Bugeon L, Cuturi MC, Hallet MM, Paineau J, Chabannes D, Soulillou JP. Peripheral tolerance of an allograft in adult rats characterized by low interleukin-2 and interferon-γ mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 1992; 54: 219.
25. Josien R, Pannetier C, Douillard P. Graft-infiltrating T helper cells, CD45RC phenotype, and TH1/TH2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. Transplantation 1995; 60: 1131.
26. Nöbner E, Goldberg JE, Naftzger C, Lyu SC, Clayberger C, Krensky AM. HLA- derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family: immunomodulatory HLA-derived peptides bind to HSP70. J Exp Med 1996; 183: 339.
27. Allen PM. Peptides in positive and negative selection: a delicate balance. Cell 1996; 76: 593.
28. Raulet DH, Help W. Natural killer cell receptors: the off and ons of NK cell recognition. Cell 1995; 82: 697.
29. Phillips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995; 268: 403.